Sheets Smith Wealth Management Immunity Bio, Inc. Transaction History

Sheets Smith Wealth Management

$789 Million
Q1 2025

A detailed history of Sheets Smith Wealth Management transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 633,475 shares of IBRX stock, worth $1.7 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

633,475

Previous 633,975 0.08%

Holding current value

$1.7 Million

Previous $1.62 Million 17.51%

% of portfolio

0.24%

Previous 0.2%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	SELL	$2.32 - $3.9 $1,160 - $1,950	-500 Reduced 0.08%	633,475 $1.91 Million
Q4 2024 Jan 17, 2025	SELL	$2.56 - $6.17 $81,971 - $197,563	-32,020 Reduced 4.81%	633,975 $1.62 Million
Q2 2024 Jul 30, 2024	SELL	$4.82 - $9.15 $1.35 Million - $2.56 Million	-279,725 Reduced 29.58%	665,995 $4.21 Million
Q1 2024 May 08, 2024	BUY	$3.23 - $6.17 $2.42 Million - $4.62 Million	749,041 Added 380.84%	945,720 $5.08 Million
Q4 2023 Feb 06, 2024	SELL	$1.25 - $5.21 $96,500 - $402,212	-77,200 Reduced 28.19%	196,679 $987,000
Q3 2023 Oct 23, 2023	BUY	$1.29 - $3.1 $6,127 - $14,725	4,750 Added 1.76%	273,879 $462,000
Q2 2023 Aug 09, 2023	SELL	$1.53 - $6.41 $2.02 Million - $8.47 Million	-1,321,269 Reduced 83.08%	269,129 $748,000
Q1 2023 May 26, 2023	BUY	$1.35 - $4.78 $2.15 Million - $7.6 Million	1,590,396 Added 0.0%	1,590,398 $2.89 Million
Q1 2023 May 12, 2023	SELL	$1.35 - $4.78 $2.08 Million - $7.38 Million	-1,544,046 Reduced 100.0%	2 $0
Q4 2022 Mar 08, 2023	BUY	$4.35 - $6.77 $5.81 Million - $9.05 Million	1,336,122 Added 642.59%	1,544,048 $7.83 Million
Q2 2022 Jul 27, 2022	BUY	$2.68 - $6.14 $10,854 - $24,867	4,050 Added 1.99%	207,926 $773,000
Q1 2022 May 02, 2022	BUY	$5.05 - $7.53 $260,580 - $388,548	51,600 Added 33.89%	203,876 $1.14 Million
Q4 2021 Jan 20, 2022	BUY	$5.67 - $10.18 $172,101 - $308,993	30,353 Added 24.9%	152,276 $926,000
Q3 2021 Oct 15, 2021	BUY	$9.17 - $14.24 $309,670 - $480,884	33,770 Added 38.31%	121,923 $1.19 Million
Q2 2021 Aug 03, 2021	BUY	$13.41 - $22.4 $891,805 - $1.49 Million	66,503 Added 307.17%	88,153 $1.26 Million
Q1 2021 Apr 23, 2021	BUY	$12.83 - $42.25 $277,769 - $914,712	21,650 New	21,650 $514,000

Others Institutions Holding IBRX

# of Institutions

236

Shares Held

82.4M

Call Options Held

1.02M

Put Options Held

2.25M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.08B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Immunity Bio, Inc. Transaction History